SCHEMBL337052

SCHEMBL337052

CNC1CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL170691 1.00
SCHEMBL907752 1.00
Hydrochloric Acid SCHEMBL31691858 0.97
Hydrochloric Acid SCHEMBL7011249 0.97
Hydrochloric Acid SCHEMBL584603 0.97
SCHEMBL907697 0.84
SCHEMBL3318759 0.84
SCHEMBL907956 0.84
SCHEMBL129977 0.82
SCHEMBL20281600 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1049 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118257018-A Modified polyester fiber and preparation method and application thereof 江苏恒科新材料有限公司 2024-06-28 CN claimed
WO-2023239227-A1 NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT 주식회사 사피엔스바이오 2023-12-14 WO claimed
EP-4259637-A1 H4 ANTAGONIST COMPOUNDS Heptares Therapeutics Limited (GB) 2023-10-18 EP claimed
WO-2022129890-A1 H4 ANTAGONIST COMPOUNDS HEPTARES THERAPEUTICS LIMITED (GB) 2022-06-23 WO claimed
CN-111777913-B Preparation method of electrostatic protection epoxy self-leveling colored sand 广东耐迪化工有限公司 2021-10-29 CN claimed
CN-111671767-A Proton-binding polymers for oral administration 特里赛达公司 2020-09-18 CN claimed
CN-111671766-A Proton-binding polymers for oral administration 特里赛达公司 2020-09-18 CN claimed
CN-105377270-B Proton-binding polymers for oral administration 特里赛达公司 2020-09-04 CN claimed
CN-110669058-A Tricyclic quinolone carboxylic acid and preparation method thereof 江西农业大学 2020-01-10 CN claimed
US-20190209607-A1 COMPOSITIONS FOR TREATING ACID-BASE DISORDERS TRICIDA, INC. 2019-07-11 US claimed
WO-2004039796-A1 HETEROARYLOXY-SUBSTITUTED PHENYLAMINOPYRIMIDINES AS RHO-KINASE INHIBITORS BAYER HEALTHCARE AG (DE) 2004-05-13 WO claimed
US-20030226216-A1 Novel 6-alkoxy-2,3-diaminopyridine couplers for dyeing keratin fibres L'OREAL S.A. (FR) 2003-12-11 US claimed
WO-2003080610-A1 IMIDAZOPYRIDINE DERIVATIVES AS KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 2003-10-02 WO claimed
US-20030163876-A1 Novel 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2003-09-04 US claimed
EP-1336606-A1 6-Alkoxy-2,3-diaminopyridine couplers for dying keratin fibers L'OREAL (FR) 2003-08-20 EP claimed
EP-1312606-A1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres L'OREAL (FR) 2003-05-21 EP claimed
CN-1378537-A Pyrimidine derivatives ASTRAZENECA AB (SE) 2002-11-06 CN claimed
EP-1226126-A1 PYRIMIDINE DERIVATIVES AstraZeneca AB (SE) 2002-07-31 EP claimed
WO-2001027089-A1 PYRIMIDINE DERIVATIVES ASTRAZENECA AB (SE) 2001-04-19 WO claimed
US-5409933-A Antibiotics KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 1995-04-25 US claimed